Reilly R, Lee N, Houle S, Law J, Marks A
Division of Nuclear Medicine, Toronto Hospital, Canada.
Int J Rad Appl Instrum A. 1992 Aug;43(8):961-7. doi: 10.1016/0883-2889(92)90214-y.
Monoclonal antibody 2G3 directed against a high molecular weight glycoprotein on breast and ovarian cancer cells was conjugated with bicyclic DTPA (or EDTA) anhydride or benzyl isothiocyanate DTPA (benzyl DTPA) and labeled with 111In. DTPA anhydride was more reactive with the antibody than benzyl DTPA, and kinetics of labeling with 111In were more rapid for DTPA substituted 2G3 than for benzyl DTPA substituted 2G3. On the other hand, 111In-2G3 conjugates prepared using DTPA anhydride were subject to more extensive dimerization and higher losses in immunoreactivity than those prepared using benzyl DTPA. On the basis of measurement of transchelation to transferrin, the stability of 111In-2G3 prepared using DTPA anhydride or benzyl DTPA did not differ during incubation in human plasma for 6 days at 37 degrees C. These results suggest that an important advantage of benzyl DTPA over DTPA anhydride for preparing 111In-labeled antibodies is the prevention of intermolecular (and intramolecular) crosslinking during conjugation which ultimately leads to alterations in conformation and losses in immunoreactivity of the radioimmunoconjugate.
针对乳腺癌和卵巢癌细胞上一种高分子量糖蛋白的单克隆抗体2G3与双环二乙三胺五乙酸(或乙二胺四乙酸)酸酐或苄基异硫氰酸酯二乙三胺五乙酸(苄基二乙三胺五乙酸)偶联,并用111铟进行标记。二乙三胺五乙酸酸酐与抗体的反应性比苄基二乙三胺五乙酸更高,并且用111铟标记时,二乙三胺五乙酸取代的2G3的动力学比苄基二乙三胺五乙酸取代的2G3更快。另一方面,使用二乙三胺五乙酸酸酐制备的111铟 - 2G3偶联物比使用苄基二乙三胺五乙酸制备的偶联物经历更广泛的二聚化且免疫反应性损失更高。基于对转铁蛋白的转螯合作用的测量,在37℃下于人体血浆中孵育6天期间,使用二乙三胺五乙酸酸酐或苄基二乙三胺五乙酸制备的111铟 - 2G3的稳定性没有差异。这些结果表明,苄基二乙三胺五乙酸相对于二乙三胺五乙酸酸酐在制备111铟标记抗体方面的一个重要优势是在偶联过程中防止分子间(和分子内)交联,这最终会导致放射免疫偶联物的构象改变和免疫反应性损失。